Lanean...
Monitoring rFVIII Prophylaxis Dosing Using Global Hemostasis Assays
INTRODUCTION: Secondary FVIII prophylaxis converts severe hemophiliacs (FVIII:C < 1 IU dL(−1)) to a moderate phenotype (FVIII:C ≥ 1 IU dL(−1)), however, plasma FVIII:C is a poor predictor of bleeding risk. AIM: To study the use of thromboelastography (TEG) and thrombin generation assay (TGA) to q...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3633647/ https://ncbi.nlm.nih.gov/pubmed/23510278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.12110 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|